NuSight Medical was founded to bring relief to the millions of Dry Eye sufferers around the world. Since 2012, the patented NuLids System® has been developed, refined, tested, and proven safe and effective in multiple studies and a published clinical trial as the first line, at-home treatment for Meibomian Gland Dysfunction, blepharitis, and related conditions.
Over 8,000 high-quality, American-made NuLids Systems have been delivered into 11 countries to date. As an FDA registered Class I device, NuLids can be sold through ophthalmologists and optometrists or directly to consumers.
With over 100 years of eye care medical device industry experience, the leadership team at NuSight Medical has assembled an organization that provides fast and effective customer support in all aspects of technical support, training, sales, marketing, social marketing, and service. NuSight Medical delivers quality products and excellent customer support.
